Latest Conference Articles

Pivotal subretinal gene therapy trial begins

Pivotal subretinal gene therapy trial begins

May 27th 2021

Angiogenesis

RGX-314 eyed by investigators as a therapeutic option for exudative AMD.

Investigating inflammation caused by intravitreal brolucizumab

Investigating inflammation caused by intravitreal brolucizumab

May 25th 2021

Angiogenesis

Preexisting neutralizing antibodies associated with the inflammatory changes.

Retinal leakage and nonperfusion linked with center-involved DME

Retinal leakage and nonperfusion linked with center-involved DME

May 20th 2021

Angiogenesis

Study results show that aflibercept-treated eyes are protected.

Treating chronic uveitis with fluocinolone acetonide implants

Treating chronic uveitis with fluocinolone acetonide implants

May 18th 2021

AAO

Study results show the device offers an effective long-term option for patients.

Gene therapy offers first steps in treatment of achromatopsia

Gene therapy offers first steps in treatment of achromatopsia

May 14th 2021

ARVO

Mark Pennesi, MD, PhD, reports during ARVO 2021 that preliminary results have shown that AGTC-401 and AGTC-402 seem safe and well tolerated in patients with ACHM.

Foveal morphologic changes in LCA sparked by gene therapy

Foveal morphologic changes in LCA sparked by gene therapy

May 10th 2021

ARVO

In a presentation at ARVO, Friederike Kortuem, MD, MSc, explains that treatment with voretigene neparvovec-rzyl led to a short-term change in the foveal morphology in a patient with visual impairment that included nyctalopia and decreased visual acuity in early childhood.

Analysis of 24-month data from the PALADIN study

Analysis of 24-month data from the PALADIN study

May 7th 2021

ARVO

Michael A. Singer, MD, speaks on the highlights of his presentation focusing on IOP in the PALADIN 24-month data intravitreal steroid (ILUVIEN).

A look at real-world trial data replication outcomes from IRIS Registry data

A look at real-world trial data replication outcomes from IRIS Registry data

May 6th 2021

ARVO

Theodore Leng, MD, discusses the highlights from his presentation on "AAO IRIS Registry Data Replicates VIEW 1 and VIEW 2 Clinical Trial Outcome Data," during the virtual 2021 ARVO meeting.

Linking patient imaging data to AAO IRIS Registry

Linking patient imaging data to AAO IRIS Registry

May 6th 2021

ARVO

Michael Mbagwu, MD, speaks on the highlights of his virtual 2021 ARVO presentation regarding the development of an algorithm tool that links patient imaging to their clinical data, specifically within the AAO IRIS Registry.

Analyzing clinical results of dexamethasone implant effect on macular thickness

Analyzing clinical results of dexamethasone implant effect on macular thickness

May 5th 2021

ARVO

Daniel F. Kiernan, MD, discusses key findings of a clinical study analyzing the effect of dexamethasone intracameral drug-delivery suspension on macular thickness based on OCT testing following vitreoretinal surgery.